Characterizing the spatiotemporal heterogeneity of the COVID-19 vaccination landscape
Open accessPreprint — published as 10.1093/aje/kwac080
The DOI matches its Crossref record; 42 of the 42 references it cites were found in a registry or an index.
Abstract
It is critical that we maximize vaccination coverage across the United States so that SARS-CoV-2 transmission can be suppressed, and we can sustain the recent reopening of the nation. Maximizing vaccination requires that we track vaccination patterns to measure the progress of the vaccination campaign and target locations that may be undervaccinated. To improve efforts to track and characterize COVID-19 vaccination progress in the United States, we integrate CDC and state-provided vaccination data, identifying and rectifying discrepancies between these data sources. We find that COVID-19 vaccination coverage in the US exhibits significant spatial heterogeneity at the county level and statistically identify spatial clusters of undervaccination, all with foci in the southern US. Vaccination progress at the county level is also variable; many counties stalled in vaccination into June 2021 and few recovered by July, with transmission of the Delta variant rapidly rising. Using a comparison with a mechanistic growth model fitted to our integrated data, we classify vaccination dynamics across time at the county scale. Our findings underline the importance of curating accurate, fine-scale vaccination data and the continued need for widespread vaccination in the US, especially in the wake of the highly transmissible Delta variant.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
brms : An R Package for Bayesian Multilevel Models Using Stan
Bürkner, P.-C. (2017) · Journal of Statistical Software · doi:10.18637/jss.v080.i01 · Cited by 9,476
Stan : A Probabilistic Programming Language
Carpenter, B., Gelman, A., Hoffman, M. D., Lee, D., Goodrich, B., Betancourt, M., Brubaker, M., Guo, J., Li, P., & Riddell, A. (2017) · Journal of Statistical Software · doi:10.18637/jss.v076.i01 · Cited by 7,754
Kulldorff, M. (1997) · Communications in Statistics - Theory and Methods · doi:10.1080/03610929708831995 · Cited by 3,939
Effectiveness of COVID-19 vaccines against the Omicron (B.1.1.529) variant of concern
Andrews, N., Stowe, J., Kirsebom, F., Toffa, S., Rickeard, T., Gallagher, E., Gower, C., Kall, M., Groves, N., O’Connell, A.-M., et al. (2021) · doi:10.1101/2021.12.14.21267615 · Cited by 2,420
Brewer, N. T., Chapman, G. B., Gibbons, F. X., Gerrard, M., McCaul, K. D., & Weinstein, N. D. (2007) · Health Psychology · doi:10.1037/0278-6133.26.2.136 · Cited by 2,046
Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M. A., Aliabadi, S., Seaman, S. R., Harris, R. J., Hope, R., Lopez-Bernal, J., et al. (2022) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00475-8 · Cited by 803
The Impact of Vaccination on Coronavirus Disease 2019 (COVID-19) Outbreaks in the United States
Moghadas, S. M., Vilches, T. N., Zhang, K., Wells, C. R., Shoukat, A., Singer, B. H., Meyers, L. A., Neuzil, K. M., Langley, J. M., Fitzpatrick, M. C., et al. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab079 · Cited by 678
Phadke, V. K., Bednarczyk, R. A., Salmon, D. A., & Omer, S. B. (2016) · JAMA · doi:10.1001/jama.2016.1353 · Cited by 674
Lauring, A. S., Tenforde, M. W., Chappell, J. D., Gaglani, M., Ginde, A. A., McNeal, T., Ghamande, S., Douin, D. J., Talbot, H. K., Casey, J. D., et al. (2022) · BMJ · doi:10.1136/bmj-2021-069761 · Cited by 656
Twohig, K. A., Nyberg, T., Zaidi, A., Thelwall, S., Sinnathamby, M., Aliabadi, S., Seaman, S. R., Harris, R., Hope, R., Bernal, J. L., et al. (2021) · Northumbria Research Link (Northumbria University) · doi:10.17863/cam.76294 · Cited by 514
Brown, C. M., Vostok, J., Johnson, H., Burns, M., Gharpure, R., Sami, S., Sabo, R. T., Hall, N., Foreman, A., Schubert, P. L., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7031e2 · Cited by 504
Immunological characteristics govern the transition of COVID-19 to endemicity
Lavine, J. S., Bjornstad, O. N., & Antia, R. (2021) · Science · doi:10.1126/science.abe6522 · Cited by 416
Nasreen, S., Chung, H., He, S., Brown, K. A., Gubbay, J. B., Buchan, S. A., Fell, D. B., Austin, P. C., Schwartz, K. L., Sundaram, M. E., et al. (2022) · Nature Microbiology · doi:10.1038/s41564-021-01053-0 · Cited by 344
Omer, S. B., Enger, K. S., Moulton, L. H., Halsey, N. A., Stokley, S., & Salmon, D. A. (2008) · American Journal of Epidemiology · doi:10.1093/aje/kwn263 · Cited by 326
Hughes, M. M., Wang, A., Grossman, M. K., Pun, E., Whiteman, A., Deng, L., Hallisey, E., Sharpe, J. D., Ussery, E. N., Stokley, S., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7012e1 · Cited by 240
Nonmedical Vaccine Exemptions and Pertussis in California, 2010
Atwell, J. E., Van Otterloo, J., Zipprich, J., Winter, K., Harriman, K., Salmon, D. A., Halsey, N. A., & Omer, S. B. (2013) · Pediatrics · doi:10.1542/peds.2013-0878 · Cited by 212
Association Between Caseload Surge and COVID-19 Survival in 558 U.S. Hospitals, March to August 2020
Kadri, S. S., Sun, J., Lawandi, A., Strich, J. R., Busch, L. M., Keller, M., Babiker, A., Yek, C., Malik, S., Krack, J., et al. (2021) · Annals of Internal Medicine · doi:10.7326/m21-1213 · Cited by 209
Barry, V., Dasgupta, S., Weller, D. L., Kriss, J. L., Cadwell, B. L., Rose, C., Pingali, C., Musial, T., Sharpe, J. D., Flores, S. A., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7022e1 · Cited by 205
Confronting the Delta Variant of SARS-CoV-2, Summer 2021
del Rio, C., Malani, P. N., & Omer, S. B. (2021) · JAMA · doi:10.1001/jama.2021.14811 · Cited by 189
COVID-19 Vaccination Coverage Among Adults — United States, December 14, 2020–May 22, 2021
Diesel, J., Sterrett, N., Dasgupta, S., Kriss, J. L., Barry, V., Vanden Esschert, K., Whiteman, A., Cadwell, B. L., Weller, D., Qualters, J. R., et al. (2021) · MMWR. Morbidity and Mortality Weekly Report · doi:10.15585/mmwr.mm7025e1 · Cited by 175
Delta variant triggers new phase in the pandemic
Kupferschmidt, K., & Wadman, M. (2021) · Science · doi:10.1126/science.372.6549.1375 · Cited by 164
The Resurgence Of Measles In The United States, 1989-1990
ATKINSON, W. L., Orenstein, W. A., & Krugman, S. (1992) · Annual Review of Medicine · doi:10.1146/annurev.me.43.020192.002315 · Cited by 131
Accelerated vaccine rollout is imperative to mitigate highly transmissible COVID-19 variants
Sah, P., VILCHES, T. N., Moghadas, S. M., Fitzpatrick, M. C., Singer, B. H., Hotez, P. J., & Galvani, A. P. (2021) · EClinicalMedicine · doi:10.1016/j.eclinm.2021.100865 · Cited by 112
Effectiveness of COVID-19 vaccines against variants of concern, CanadaPreprint
Nasreen, S., Chung, H., He, S., et al. (2021) · medRxiv · doi:10.1101/2021.06.28.21259420 · Cited by 108
Characterizing the impact of spatial clustering of susceptibility for measles elimination
Truelove, S., Graham, M., Moss, W. J., Metcalf, C. J. E., Ferrari, M. J., & Lessler, J. (2018) · Vaccine · doi:10.1016/j.vaccine.2018.12.012 · Cited by 77
Masters, N. B., Eisenberg, M. C., Delamater, P. L., Kay, M., Boulton, M. L., & Zelner, J. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.2011529117 · Cited by 72
Hospitalisation associated with SARS-CoV-2 delta variant in Denmark
Bager, P., Wohlfahrt, J., Rasmussen, M., Albertsen, M., & Krause, T. G. (2021) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(21)00580-6 · Cited by 71
Measuring Immunization Coverage among Preschool Children: Past, Present, and Future Opportunities
Salmon, D. A., Smith, P. J., Navar, A. M., Pan, W. K. Y., Omer, S. B., Singleton, J. A., & Halsey, N. A. (2006) · Epidemiologic Reviews · doi:10.1093/epirev/mxj001 · Cited by 49
Jain, V., Schwarz, L., & Lorgelly, P. K. (2021) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph18073483 · Cited by 46
Association of COVID-19-Related Hospital Use and Overall COVID-19 Mortality in the USA
Karaca‐Mandic, P., Sen, S., Georgiou, A., Zhu, Y. M., & Basu, A. (2020) · Journal of General Internal Medicine · doi:10.1007/s11606-020-06084-7 · Cited by 45
Covid-19: Delta infections threaten herd immunity vaccine strategy
Dyer, O. (2021) · BMJ · doi:10.1136/bmj.n1933 · Cited by 45
Characterizing the Spatiotemporal Heterogeneity of the COVID-19 Vaccination Landscape
Tiu, A. C., Susswein, Z., Merritt, A., & Bansal, S. (2022) · American Journal of Epidemiology · doi:10.1093/aje/kwac080 · Cited by 39
Self-citationKundrick, A., Huang, Z., Carran, S., Kagoli, M., Grais, R. F., Hurtado, N., & Ferrari, M. J. (2018) · BMC Public Health · doi:10.1186/s12889-018-5628-x · Cited by 32
Monitoring County-Level Vaccination Coverage During the 2004–2005 Influenza Season
Jia, H., Link, M., HOLT, J., Mokdad, A. H., Li, L., & Levy, P. S. (2006) · American Journal of Preventive Medicine · doi:10.1016/j.amepre.2006.06.005 · Cited by 20
A framework for monitoring population immunity to SARS-CoV-2
Lopman, B. A., Shioda, K., Nguyen, Q., Beckett, S. J., Siegler, A. J., Sullivan, P. S., & Weitz, J. S. (2021) · Annals of Epidemiology · doi:10.1016/j.annepidem.2021.08.013 · Cited by 17
Grumbach, K., Carson, M. S., & Harris, O. (2021) · JAMA Health Forum · doi:10.1001/jamahealthforum.2021.1724 · Cited by 16
Jain, V., Schwarz, L., & Lorgelly, P. K. (2021) · medRxiv · doi:10.1101/2021.03.11.21253411 · Cited by 14
Susswein, Z., Valdano, E., Brett, T. S., Rohani, P., Colizza, V., & Bansal, S. (2021) · medRxiv · doi:10.1101/2021.08.09.21261807 · Cited by 13
Self-citationKluberg, S. A., McGinnis, D. P., Hswen, Y., Majumder, M. S., Santillana, M., & Brownstein, J. S. (2017) · Vaccine · doi:10.1016/j.vaccine.2017.09.080 · Cited by 7
Chernyavskiy, P., Richardson, J. W., & Ratcliffe, S. J. (2021) · medRxiv · doi:10.1101/2021.05.28.21257946 · Cited by 6
King County non-profit fights against COVID-19 vaccine hesitancy
Kim, H. (2021) · Q13 FOX · Cited by 1
Cited by
Unrepresentative big surveys significantly overestimated US vaccine uptake
Bradley, V. C., Kuriwaki, S., Isakov, M., Sejdinovic, D., Meng, X.-L., & Flaxman, S. (2021) · Nature · doi:10.1038/s41586-021-04198-4 · Cited by 248
Moral values predict county-level COVID-19 vaccination rates in the United States.
Reimer, N. K., Atari, M., Karimi-Malekabadi, F., Trager, J., Kennedy, B., Graham, J., & Dehghani, M. (2022) · American Psychologist · doi:10.1037/amp0001020 · Cited by 73
Klaassen, F., Chitwood, M. H., Cohen, T., Pitzer, V. E., Russi, M., Swartwood, N. A., Salomon, J. A., & Menzies, N. A. (2023) · Clinical Infectious Diseases · doi:10.1093/cid/ciad210 · Cited by 65
Spatial clustering in vaccination hesitancy: The role of social influence and social selection
Alvarez-Zuzek, L. G., Zipfel, C. M., & Bansal, S. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010437 · Cited by 60
Self-citationGlobal diversity of policy, coverage, and demand of COVID-19 vaccines: a descriptive study
Chen, Z., Zheng, W., Wu, Q., Chen, X., Peng, C., Tian, Y., Sun, R., Dong, J., Wang, M., Zhou, X., et al. (2022) · BMC Medicine · doi:10.1186/s12916-022-02333-0 · Cited by 57
Metadata
- Authors
- Tiu, A., Susswein, Z., Merritt, A., & Bansal, S.
- Affiliations
- Georgetown University (US)
- Corresponding author
- Bansal, Shweta
- Venue
- American Journal of Epidemiology
- Publisher
- openRxiv
- Published
- 2021-10-07
- Volume
- 191
- Issue
- 10
- Pages
- 1792-1802
- ISSN
- 0002-9262 (ISSN-L)
- PMC
- PMC9129108
- OpenAlex
- W4225565798
- Cited by
- 37
- References
- 42
- Citations by year
- 2026: 3 · 2025: 7 · 2024: 9 · 2023: 9 · 2022: 8 · 2021: 1
- FWCI
- 4.89
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- American Journal of Epidemiology (publishedVersion)
- medRxiv (acceptedVersion, cc-by-nc-nd)
- PubMed Central (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Georgetown University
- National Institutes of Health
- Centers for Disease Control and Prevention
- National Institute of General Medical Sciences (R01GM123007)
- Topics
- Physical Sciences › Mathematics › Modeling and Simulation › COVID-19 epidemiological studies
- Social Sciences › Health › Vaccine Coverage and Hesitancy
- Health Sciences › Medicine › Infectious Diseases › SARS-CoV-2 and COVID-19 Research
- Keywords
- COVID-19 vaccination coverage, SARS-CoV-2, spatiotemporal heterogeneity, multi-source data fusion, Delta variant, mechanistic growth model, vaccination targeting, United States
- MeSH terms
- COVID-19, SARS-CoV-2, COVID-19 Vaccines, Humans, United States, Vaccination
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.